Molina Healthcare (NYSE:MOH) Price Target Raised to $151.00

Molina Healthcare (NYSE:MOH) had its price target boosted by UBS Group from $145.00 to $151.00 in a research report released on Thursday morning,Benzinga reports. UBS Group currently has a neutral rating on the stock.

Several other research firms have also recently weighed in on MOH. Mizuho dropped their price target on Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a report on Thursday. Cantor Fitzgerald decreased their price objective on Molina Healthcare from $180.00 to $144.00 and set a “neutral” rating on the stock in a report on Monday, February 9th. Barclays lowered their price objective on Molina Healthcare from $164.00 to $133.00 and set an “underweight” rating on the stock in a research report on Tuesday, February 10th. The Goldman Sachs Group reduced their target price on shares of Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research report on Wednesday, February 11th. Finally, Deutsche Bank Aktiengesellschaft set a $109.00 price target on shares of Molina Healthcare in a research note on Tuesday, February 10th. Two investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Molina Healthcare currently has an average rating of “Hold” and a consensus price target of $169.21.

Molina Healthcare Stock Down 0.1%

MOH opened at $149.08 on Thursday. Molina Healthcare has a 1-year low of $121.06 and a 1-year high of $359.97. The stock’s fifty day simple moving average is $163.64 and its 200 day simple moving average is $167.11. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.97. The stock has a market cap of $7.68 billion, a PE ratio of 17.42 and a beta of 0.52.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). The company had revenue of $11.38 billion during the quarter, compared to analyst estimates of $10.90 billion. Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. Molina Healthcare’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.05 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, research analysts expect that Molina Healthcare will post 24.4 earnings per share for the current year.

Institutional Investors Weigh In On Molina Healthcare

A number of large investors have recently modified their holdings of the business. AQR Capital Management LLC boosted its stake in Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after buying an additional 2,008,458 shares in the last quarter. 8 Knots Management LLC bought a new position in Molina Healthcare in the fourth quarter valued at about $198,942,000. Victory Capital Management Inc. raised its stake in Molina Healthcare by 344.3% during the third quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock worth $184,380,000 after acquiring an additional 746,639 shares in the last quarter. Norges Bank bought a new position in shares of Molina Healthcare in the second quarter worth about $212,113,000. Finally, Madison Avenue Partners LP bought a new position in shares of Molina Healthcare in the fourth quarter worth about $110,003,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.